AlloSource's president and CEO, Tom Cycyota, plans to retire after leading the biologics company for 22 years.
Biologics
Anika Therapeutics earned the American Orthopedic Society for Sports Medicine's ACE award for cutting-edge innovation for its Tactoset product.
Five orthopedic surgeons are part of a new regenerative medicine scientific advisory board for Mimedx.
Orthofix's Virtuos Lyograft allograft was debuted by neurosurgeon Thomas Ellis, MD.
NovaBone, a biologic medtech company focused on orthopedic and dental products, hired Brian Carlisle as CEO.
Advertisement
From a notable stem cell study to newly launched products, here are eight updates in regenerative orthopedic medicine:
Ossifix Orthopedics will launch its demineralized bone matrix, made from 100 percent human bone tissue in August.
The Pediatric Orthopedic Center in Cedar Knolls, N.J., became the first pediatric-only orthopedic practice in its region to add the Bear implant for ACL restoration.
Scientists in the U.K. have found that a new drug being tested for cancer therapy may also be able to reduce damage in patients with spinal cord injuries.
Spiderwort, a startup developing cellulose-based tissue scaffolding to treat acute spinal cord injuries, has secured $13.2 million through a series A financing round, the company said July 12.